Perry M Novak

Title: The Innovative Journey of Inventor Perry M. Novak

Introduction

Perry M. Novak is a notable inventor based in Ann Arbor, MI, with a commendable portfolio of two patents. His contributions to the field of pharmaceuticals and cerebrovascular treatments reflect a deep commitment to innovation and the advancement of medical science.

Latest Patents

One of Perry's latest inventions is titled "Substituted .alpha.-amino acids having selected acidic moieties for use." This novel invention focuses on substituted .alpha.-amino acids, pharmaceutical compositions, and methods for treating disorders that benefit from the blockade of aspartate and glutamate receptors. Another significant patent is "Polycyclic amines useful as cerebrovascular agents," which unveils a new series of polycyclic amines, their derivatives, methods of making the compounds, along with innovative intermediates. This patent outlines compositions containing these amines and their methods of use in treating and preventing cerebrovascular disorders.

Career Highlights

Throughout his career, Perry has made substantial contributions to various companies. Notably, he has worked with Warner-Lambert Company, where he further refined his expertise in pharmaceutical innovation and development.

Collaborations

Perry has had the opportunity to collaborate with talented individuals such as Graham Johnson and Christopher Franklin Bigge. Working alongside these professionals has sparked creativity and facilitated the development of groundbreaking inventions.

Conclusion

In summary, Perry M. Novak is an inventive force in the field of pharmaceuticals, holding significant patents that aim to revolutionize treatment options for considerable medical issues. His collaborative efforts and experience in established companies underscore his dedication to innovation and the betterment of health through novel inventions.